Lion Street Advisors, LLC Amgen Inc Transaction History

Lion Street Advisors, LLC

$282 Million
Q3 2024

A detailed history of Lion Street Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Lion Street Advisors, LLC holds 2,276 shares of AMGN stock, worth $601,979. This represents 0.26% of its overall portfolio holdings.

Number of Shares

2,276

Previous 2,292 0.7%

Holding current value

$601,979

Previous $716,000 2.37%

% of portfolio

0.26%

Previous 0.27%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$309.38 - $337.38 $4,950 - $5,398	-16 Reduced 0.7%	2,276 $733,000
Q2 2024 Jul 12, 2024	SELL	$262.75 - $319.31 $8,408 - $10,217	-32 Reduced 1.38%	2,292 $716,000
Q4 2023 Jan 09, 2024	SELL	$255.7 - $288.46 $648,199 - $731,246	-2,535 Reduced 52.17%	2,324 $669,000
Q3 2023 Oct 19, 2023	BUY	$218.65 - $271.46 $264,785 - $328,738	1,211 Added 33.2%	4,859 $1.31 Million
Q2 2023 Jul 28, 2023	SELL	$214.27 - $253.37 $264,409 - $312,658	-1,234 Reduced 25.28%	3,648 $809,000
Q1 2023 Apr 12, 2023	BUY	$225.79 - $275.2 $396,713 - $483,526	1,757 Added 56.22%	4,882 $1.18 Million
Q4 2022 Jan 19, 2023	SELL	$229.03 - $291.01 $357,515 - $454,266	-1,561 Reduced 33.31%	3,125 $0
Q3 2022 Oct 18, 2022	BUY	$224.46 - $253.15 $350,382 - $395,167	1,561 Added 49.95%	4,686 $1.06 Million
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $21,225 - $23,620	-92 Reduced 2.86%	3,125 $643,000
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $3,289 - $3,638	-15 Reduced 0.46%	3,217 $775,000
Q4 2021 Jan 20, 2022	BUY	$198.88 - $227.6 $21,280 - $24,353	107 Added 3.42%	3,232 $723,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $663,343 - $777,187	3,125 New	3,125 $665,000
Q2 2020 Jul 20, 2020	SELL	$197.81 - $242.74 $21,956 - $26,944	-111 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $20,228 - $26,828	111 New	111 $23,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lion Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lion Street Advisors, LLC with notifications on news.

Account

Lion Street Advisors, LLC Amgen Inc Transaction History